View source for Androgen insensitivity syndrome CT

__NOTOC__
{{Androgen insensitivity syndrome}}
{{CMG}} ;{{AE}} {{ARK}}

==Overview==
Findings of seminoma are observed by [[FDG-PET|FDG]] [[PET scan|PET]]/[[CT-scans|CT]] in androgen insensitivity syndrome. Detection of [[sertoli-Leydig cell tumor]] accidentally is by [[FDG-PET]]/[[CT]] imaging.

==CT==
*[[FDG-PET]]/[[CT]] findings are observed of seminoma in androgen insensitivity syndrome.<ref name="pmid28604478">{{cite journal| author=Han EJ, O JH, Park G, Lee J| title=FDG PET/CT Image of Seminoma in Androgen Insensitivity Syndrome. | journal=Clin Nucl Med | year= 2017 | volume= 42 | issue= 8 | pages= e381-e382 | pmid=28604478 | doi=10.1097/RLU.0000000000001722 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28604478  }} </ref>
*[[PET]] images showed focal [[FDG]] uptake in the left pelvic sidewall, and a hypodense lesion with calcifications was noted in the corresponding [[CT]] images.
*Another smaller hypodense lesion with calcifications was noted in the right pelvic sidewall, but faint [[FDG]] uptake.
*Detection of [[sertoli-Leydig cell tumor]] accidentally is by [[FDG-PET]]/[[CT]] imaging. An F-18 fluorodeoxyglucose [[PET]] study, and a pathologically increased [[FDG]] uptake at the left lower abdomen was detected corresponding to a solid, cystic lesion on [[CT]] images. <ref name="pmid19957213">{{cite journal| author=Ozülker T, Ozpaçaci T, Ozülker F, Ozekici U, Bilgiç R, Mert M| title=Incidental detection of Sertoli-Leydig cell tumor by FDG PET/CT imaging in a patient with androgen insensitivity syndrome. | journal=Ann Nucl Med | year= 2010 | volume= 24 | issue= 1 | pages= 35-9 | pmid=19957213 | doi=10.1007/s12149-009-0321-x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19957213  }} </ref>

==References==
{{Reflist|2}}

[[Category:Endocrinology]]

{{WH}}
{{WS}}